BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 3005953)

  • 1. Cirrhosis and hepatocellular carcinoma in a patient with heterozygous (MZ) alpha-1-antitrypsin deficiency.
    Marwick TH; Cooney PT; Kerlin P
    Pathology; 1985 Oct; 17(4):649-52. PubMed ID: 3005953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. alpha 1-Antitrypsin deficiency and hepatocellular carcinoma. Association with cirrhosis, copper storage, and Mallory bodies.
    Rubel LR; Ishak KG; Benjamin SB; Knuff TE
    Arch Pathol Lab Med; 1982 Dec; 106(13):678-81. PubMed ID: 6291490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocellular carcinoma and partial deficiency of alpha-1 antitrypsin (MZ).
    Rawlings W; Moss J; Cooper HS; Hamilton SR
    Ann Intern Med; 1974 Dec; 81(6):771-3. PubMed ID: 4372920
    [No Abstract]   [Full Text] [Related]  

  • 4. Hepatocellular carcinoma in a patient with sarcoidosis-associated chronic active hepatitis and the MZ alpha-1-antitrypsin phenotype.
    Kronborg IJ; Bhathal PS; Mackay IR; Storey E; Long TM
    Liver; 1983 Apr; 3(2):92-9. PubMed ID: 6308380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha-1-antitrypsin globules in liver biopsies.
    Clausen PP
    Acta Pathol Microbiol Scand A; 1980 Jul; 88(4):225-30. PubMed ID: 6969525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Liver and hereditary alpha 1-antitrypsin deficiency].
    Feldmann G
    Gastroenterol Clin Biol; 1993; 17(2):83-93. PubMed ID: 8388836
    [No Abstract]   [Full Text] [Related]  

  • 7. [Heterozygous alpha-1-antitrypsin deficiency (PiMZ): risk factor in the development of primary liver carcinoma in non-cirrhotic liver?].
    Manekeller S; Sauerbruch T; Fischer HP; Propping P; Hirner A
    Z Gastroenterol; 2010 Oct; 48(10):1211-4. PubMed ID: 20886426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffuse hepatocellular dysplasia and carcinoma associated with the Mmalton variant of alpha 1-antitrypsin.
    Reid CL; Wiener GJ; Cox DW; Richter JE; Geisinger KR
    Gastroenterology; 1987 Jul; 93(1):181-7. PubMed ID: 3034714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Demonstration of alpha 1-antitrypsin in paraffin sections of hepatoma and cirrhosis.
    Nakopoulou L; Theodoropoulos G; Kotsis L; Papacharalampous N
    Virchows Arch A Pathol Anat Histol; 1982; 397(2):163-70. PubMed ID: 6294975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocellular carcinoma and intermediate alpha1-antitrypsin deficiency (MZ phenotype).
    Lieberman J; Silton RM; Agliozzo CM; McMahon J
    Am J Clin Pathol; 1975 Sep; 64(3):304-10. PubMed ID: 169686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emphysema, cirrhosis, and hepatoma with alpha-1 antitrypsin deficiency.
    Lieberman J
    Ann Intern Med; 1974 Dec; 81(6):850-2. PubMed ID: 4372921
    [No Abstract]   [Full Text] [Related]  

  • 12. Liver pathology in alpha1-antitrypsin deficiency. A review.
    Cohen C
    S Afr Med J; 1975 May; 49(21):849-52. PubMed ID: 166455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver cirrhosis associated with heterozygous alpha-1-antitrypsin deficiency type Pi MS and autoimmune features.
    Löhr HF; Schlaak JF; Dienes HP; Lorenz J; Meyer zum Büschenfelde KH; Gerken G
    Digestion; 1995; 56(1):41-5. PubMed ID: 7895931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha-I-antitrypsin and copper in the liver.
    Callea F; Ray MB; Desmet VJ
    Histopathology; 1981 Jul; 5(4):415-24. PubMed ID: 6974127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous alpha-1-antitrypsin accumulation in liver and pancreas.
    Callea F; Fevery J; Desmet VJ
    Hum Pathol; 1984 Mar; 15(3):293-5. PubMed ID: 6321324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Z and Mmalton-1-antitrypsin deficiency-associated hepatocellular carcinoma: a genetic study.
    Francalanci P; Santorelli FM; Saccani S; Bonetti MF; Medicina D; Coni P; Faa G; Callea F
    Liver Int; 2009 Nov; 29(10):1593-6. PubMed ID: 19744266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of increase in heterozygous alpha 1-antitrypsin deficiency phenotypes among patients with hepatocellular and bile duct carcinoma.
    Rabinovitz M; Gavaler JS; Kelly RH; Prieto M; Van Thiel DH
    Hepatology; 1992 Mar; 15(3):407-10. PubMed ID: 1312055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cirrhosis and malignant hepatoma in alpha 1-antitrypsin deficiency.
    Eriksson S; Hägerstrand I
    Acta Med Scand; 1974 Jun; 195(6):451-8. PubMed ID: 4365922
    [No Abstract]   [Full Text] [Related]  

  • 19. Alpha-1 Antitrypsin and Hepatocellular Carcinoma in Liver Cirrhosis:
    Rabekova Z; Frankova S; Jirsa M; Neroldova M; Lunova M; Fabian O; Kveton M; Varys D; Chmelova K; Adamkova V; Hubacek JA; Spicak J; Merta D; Sperl J
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterozygous MZ alpha 1-antitrypsin deficiency in adults with chronic active hepatitis and cryptogenic cirrhosis.
    Hodges JR; Millward-Sadler GH; Barbatis C; Wright R
    N Engl J Med; 1981 Mar; 304(10):557-60. PubMed ID: 6969850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.